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Abstract
Background: Studies have indicated that altered maternal micronutrients and vitamins influence the development of
newborns and altered nutrient exposure throughout the lifetime may have potential health effects and increased
susceptibility to chronic diseases. In recent years, folic acid (FA) exposure has significantly increased as a result of mandatory
FA fortification and supplementation during pregnancy. Since FA modulates DNA methylation and affects gene expression,
we investigated whether the amount of FA ingested during gestation alters gene expression in the newborn cerebral
hemisphere, and if the increased exposure to FA during gestation and throughout the lifetime alters behavior in C57BL/6J
mice.
Methods: Dams were fed FA either at 0.4 mg or 4 mg/kg diet throughout the pregnancy and the resulting pups were
maintained on the diet throughout experimentation. Newborn pups brain cerebral hemispheres were used for microarray
analysis. To confirm alteration of several genes, quantitative RT-PCR (qRT-PCR) and Western blot analyses were performed.
In addition, various behavior assessments were conducted on neonatal and adult offspring.
Results: Results from microarray analysis suggest that the higher dose of FA supplementation during gestation alters the
expression of a number of genes in the newborns’ cerebral hemispheres, including many involved in development. QRT-
PCR confirmed alterations of nine genes including down-regulation of Cpn2, Htr4, Zfp353, Vgll2 and up-regulation of Xist,
Nkx6-3, Leprel1, Nfix, Slc17a7. The alterations in the expression of Slc17a7 and Vgll2 were confirmed at the protein level. Pups
exposed to the higher dose of FA exhibited increased ultrasonic vocalizations, greater anxiety-like behavior and
hyperactivity. These findings suggest that although FA plays a significant role in mammalian cellular machinery, there may
be a loss of benefit from higher amounts of FA. Unregulated high FA supplementation during pregnancy and throughout
the life course may have lasting effects, with alterations in brain development resulting in changes in behavior.
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Introduction
Maternal nutrition during the peri- or post-conception period is
strongly related to fetal development and the risk of non-
communicable diseases. Micronutrients including vitamins and
minerals are major intrauterine environmental factors that
regulate the fetal genome machinery and human reproductive
health [1,2]. Since the early 1970’s, the vitamin folic acid (FA) has
received considerable attention because of its important role in
alleviating neural tube defects (NTDs) [3]. In 1998, mandatory FA
fortification of breakfast cereals and grains was introduced by
several countries [4]. These guidelines are credited with a
significant reduction in NTDs in infants [5]. Intrauterine and
early life exposure to FA has increased well beyond the minimum
necessary requirements as a result of the additive levels from
fortified foodstuffs, prescriptions by physicians and over-the-
counter prenatal vitamins, as well as energy drinks [6]. Studies
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suggest that folate concentrations in the serum (57%) and red
blood cells (136%) of pregnant women were much higher than the
reported dietary folate intake (28%) [7], and concerns have been
raised about the interference of excess unmetabolized FA [8,9].
Several epidemiological reports have suggested that excess FA
increases the risk of asthma and type 2 diabetes in newborns [10–
12], and evidence of unmetabolized FA has been found in fetal
cord blood [13]. While studies have found an important role of
maternal FA in the proper closure of the neural tube, there have
been no published reports yet on whether higher FA supplemen-
tation during pregnancy and throughout life may impact brain
development. A previous studies from our laboratory has showed
that FA supplementation significantly dysregulates gene expression
in human lymphoblastoid cell lines [14], and our recent study in a
mouse model has shown that gestational FA induces substantial
alterations in methylation patterns of several genes in the cerebral
hemispheres of the offspring [15]. Studies in laboratory animals
have shown adverse effects including tumors and birth defects in
offspring exposed to higher FA concentrations, and suppression of
thyroid function with motivational and spatial memory deficits in
adolescence [6,16–22].
The current study had two objectives: first, to determine if the
amount of maternal FA supplementation during gestation
modulates gene expression in the developing cerebral hemispheres
and consequently affects neonatal behavior, and second, to explore
if gestational and lifelong exposure to excess FA alters the behavior
of the adult. We found that higher maternal FA supplementation
caused large-scale alterations in gene expression in the newborn’s
cerebral hemispheres. Additionally we found moderate alterations
in behavior in both the newborn and the adult as a result of higher
FA exposure. To our knowledge, this is the first study of its kind to
evaluate the effect of FA supplementation on global gene
expression and its correlation with behavior.
Materials and Methods
Mice Strain and Feeding
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
animal use protocol was approved by the Institute for Basic
Research Institutional Animal Care and Use Committee (IBR
IACUC), which oversees the use of laboratory animals for research
purposes (IBR IACUC approval number 401). One week prior to
mating, female mice were fed a custom AIN-93G amino acid–
based diet (Research Diet, Inc. New-Brunswick, NJ, USA),
receiving FA at 0.4 mg/kg (n= 20), while the test group received
FA at 4 mg/kg (n = 20). The 0.4 mg/kg diet level of FA is
necessary for normal healthy litter size [23], where as FA at the
level of the 4 mg/kg diet is ten times higher. These amounts were
chosen because in humans FA is prescribed at a dose of 4002
800 mg/day to every pregnant woman, and to those planning to
achieve pregnancy, and the recommended dose of FA is 10-fold
higher for women with a previous history of NTD pregnancy
(4 mg) [5].
After mating, the females were separated and housed individ-
ually until the birth of their pups. At postnatal day one (P1),
newborn pups from different dams were sacrificed, and cerebral
hemisphere tissues were collected. For the 0.4 mg group, male
pups’ n= 30 and female pups’ n= 30. Tissues from the 4 mg
group (n = 30/gender) were similarly processed. All tissues were
frozen in liquid nitrogen and from these, tissues were distributed
for RNA and protein analyses. For the remaining offspring, FA
diet was continued throughout the lifespan of the mice, and mice
were either tested for ultrasonic vocalizations (USVs) at P2, P4 and
P6 (n for 0.4 mg= 13; 4 mg=16) or allowed to age with minimal
interference for later behavioral testing. Adult male and female
offspring were behaviorally tested between 2 and 7 months of age.
When more than one male or female mouse was tested per litter,
the data were pooled so that each litter is only represented by one
male and one female score. Mice were housed 226/cage with ad
libitum food (FA diets) and water, and 12-h light/dark cycle. The
pups with the perinatal high FA treatment continued to receive
4 mg/kg FA diet after weaning till performance of the specified
behavior tests. All experiments were conducted during the light
phase between 10 am and 5 pm. These experiments were done
throughout this time window, none were done only in the morning
or the afternoon. The schematic diagram of the experimental
design for this study is shown in Figure 1.
RNA Preparation
Total RNA from P1 pups (n = 9/group/gender) was extracted
with Trizol reagent (Life Technologies, Carlsbad, CA, USA) and
further purified by Qiagen RNeasy kit (Qiagen, Valencia, CA,
USA), according to the manufacturer’s instructions. Cerebral
hemisphere tissues were pooled (n= 3/gender) for the 0.4 mg
group: three male newborn pups (each from an independent dam)
and three female newborn pups (each from an independent dam),
and tissues from the 4 mg group were similarly processed.
Considering the degree of inter-variability, RNA extractions were
further repeated twice from a different batch (pooled samples,
n = 3 for each group/gender, with each mouse from a different
dam). RNA quality was assessed by measuring the absorbance
ratio at 260/280 nm (Nanodrop 2000 spectrophotometer,
Thermo Fisher Scientific, Waltham, MA, USA), and the integrity
was assessed by formaldehyde-gel electrophoresis.
Microarrays
Microarray analysis was carried out using pooled RNA from P1
pups as previously described [14]. Total RNA was converted to
cDNA, followed by conversion to cyanine-3-labelled cRNA, using
the one-color, low-input QuickAmp labelling kit (Agilent Tech-
nologies, Santa Clara, CA, USA) by following the manufacturer’s
instructions. Purification of the cRNA was achieved with RNeasy
kit (Qiagen,), and the incorporation of cyanine-3 was assessed by a
Nano Drop spectrometer (Thermo Fisher Scientific, Waltham,
MA, USA). A total of 600 ng of cRNA from each sample was
fragmented and hybridized to the SurePrint G3 mouse gene
expression 8660 k arrays (G4852A) (Agilent Technologies). The
data were processed by Feature Extraction software v10.7.3.1 for
image analysis and initial quality control. Our Minimum
Information About a Microarray Experiment (MIAME)2compli-
ant data has been deposited in the Gene Expression Omnibus
database of the National Center for Bioinformatics, with the
accession number GSE45607 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE45607).
Data Analysis
To increase statistical power and minimize differences of
individual variability, samples were pooled from postnatal day
one pups segregated by gender for each group [24]. A total of
three microarray gene expression studies were performed for each
group per gender, and each array represents expression of pooled
n= 3/gender under the same dose of FA. The publicly available
BRB ArrayTools 4.2.12stable release was used for analyzing
microarray data [25]. The expression data were normalized
(quantile) and log-transformed. To select genes that changed
significantly between the two doses of FA, the data sets were
Aberrant Gene Expression and Behavior by Folic Acid
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passed through a number of filtering steps based on intensity filter,
P value of log intensity variation, and fold changes. For each spot,
the intensity filter of threshold to minimum 10 was used if the
intensity was below the minimum, and was further filtered by
excluding the corresponding spots for an entire gene from all
arrays having log intensity variations with a cut-off set at P.0.05.
From these selected genes, a transcript was considered differen-
tially expressed when the difference in the mean expression from
three arrays was $ two-fold.
Quantitative RT-PCR (qRT-PCR) analysis
Validation of microarray expression data was carried out by
qRT-PCR for several randomly selected transcripts that were
shown to have greater than two-fold change in expression. RT-
PCR amplification was performed with iScript kit (BioRad,
Hercules, CA, USA) by using 602100 ng of total RNA from
postnatal day one pups, by following the manufacturer’s instruc-
tions. The following RT-PCR cycle parameters were used: 50uC
for 10 min, and 95uC for 5 min followed by 40 cycles of 95uC for
15 sec and 55uC for 1 min. Relative expression was calculated
using the Pfaffl method [26]. Either Hprt1 or Gapdh were used as an
endogenous housekeeping control. The expression of these
housekeeping genes was not changed as a result of FA treatment.
The primers used in this study are listed in File S1, under Results
and Table S1.
Statistical Analysis
Each reaction was performed in triplicates and repeated twice,
each from different batches of pooled samples (n = 3 pooled
samples for each group/gender, each from different dams). Values
are presented as means 6 SD, and numerical results are presented
considering P,0.05 as significant. Data were analyzed with
Student t-test by using Prism software (GraphPad, La Jolla, CA,
USA).
Western Blot Analyses
Total cellular proteins from individual newborn pups’ whole
cerebral hemispheres (n = 2/gender/group) were used, and the
detection of targeted proteins were accomplished by incubating
with primary antibodies overnight at 4uC (anti-Slc17a7 1:500,
anti-Vgll2 1:250) followed by horseradish peroxidase (HRP)2
conjugated secondary antibody. The signal of the targeted protein
was captured using the SuperSignal West Pico chemiluminescent
substrate (Thermo Fisher Scientific, Waltham, MA, USA). Images
were captured by using a Bioimager (UVP system, Upland, CA,
USA), and analyzed by using ImageJ software (NIH).
Behavior Analyses
Behavioral experimenters were blinded to the treatments and
diet compositions that mice received. The researchers were
provided with two groups of mice and two different diet pellets
without disclosing the dietary content. Data generated as separate
groups were again analyzed without prior knowledge of the diet
composition. The experiments were run in the following order:
postnatal day 226: USVs, after which the mice were allowed to
age with minimal interference. Experiments started at 8 weeks of
age and were run in the following order: social approach, elevated
plus maze, marble-burying, self-grooming, buried food, trace fear
conditioning, and open field. These experiments were conducted
between 2 and 6 months of age. For each behavior test performed,
all the mice were of similar age in all the groups tested. This
behavioral phenotyping battery was chosen to assess the mice for
aberrant behaviors in several psychological domains.
USV. For the USV experiments the data represent mice in the
0.4 mg group, n= 13 from 10 litters with 6 males and 7 females,
and in the 4 mg group, n= 16 from 8 litters with 9 males and 7
females. Data were pooled so that no more than one female and
male represents each litter. Individual P2, P4, and P6 pups were
placed in a beaker inside of a Styrofoam box, which also contained
an ultrasonic frequency detector set to 60 kHz. The box was closed
to minimize outside noise. The frequency detectors were attached
to a computer equipped with Ultravox software (Noldus,
Attleboro, MA, USA) to analyze the number and duration of
calls. Criterion for the number of calls was minimum call duration
of 10 ms, with 5 ms of silence between vocalizations for each call
to be considered independent. The pups were separated from their
mothers and littermates for 5 minutes, with vocalization data
recorded for the entire period of separation.
Social Approach. For the social approach experiments the
data represent mice in the 0.4 mg group, n= 14 from 9 litters with
6 males and 8 females, and the 4 mg group, n= 16 from 9 litters
with 8 males and 8 females. Data were pooled so that no more
than one female and male represents each litter. Social approach
behaviors were tested in an apparatus with three chambers in a
single session, divided into three phases, as previously described
[27,28]. An upright plastic drinking cup weighed down with a lead
Figure 1. The schematic diagram of the experimental design for this study.
doi:10.1371/journal.pone.0101674.g001
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weight was placed on top of each of the inverted wire cups to
prevent the subject mouse from climbing on top. Both end
chambers maintained a lighting level of 43244 lux with two desk
lamps angled away from the maze. More details are available in
Methods S1 in File S1.
Trace Fear Conditioning. For the trace fear conditioning
experiments, the data represent mice in the 0.4 mg group, n= 16
from 10 litters with 7 males and 9 females, and the 4 mg group,
n = 16 from 10 litters with 9 males and 7 females. Data were
pooled so that no more than one female and male represents each
litter. Learning and memory abilities were assessed using a fear
conditioning procedure as previously described [29]. A fear
conditioning apparatus (ANY-maze, Stoelting, Inc., Wood Dale,
IL, USA) equipped with a digital camera interfaced to a PC with
ANY-maze software was used to score freezing. The fear
conditioning experiment was conducted in three phases on three
consecutive days: (1) trace fear training, (2) contextual fear
conditioning, and (3) cued fear conditioning.
Open Field. For the open field experiments, the data
represent mice in the 0.4 mg group, n = 15 from 9 litters with 6
males and 9 females, and the 4 mg group, n= 20 from 13 litters
with 11 males and 9 females. Data were pooled so that no more
than one female and male represents each litter. General
exploratory locomotion in a novel environment was tested by
placing mice in an open field for a 15-min test session. The open
field was a transparent plexiglass apparatus
(40 cm640 cm634.5 cm) with a grey metal floor. A camera was
positioned above the apparatus to record the mice, and the videos
were scored using video tracking software (ANY-maze). The
testing room was illuminated to 45 lux and kept at a similar
temperature as the colony room.
Statistical Analysis for Behavioral Experiments
For the social approach task, repeated measures analysis of
variance (ANOVA) was used to compare the outer chamber times.
Time spent in the center chamber is shown graphically to illustrate
where the subject mouse spent time during the entire 10-min
phase. Chamber time, time spent sniffing the stranger mouse
versus the novel object, and the number of entries to side
chambers were recorded. Newman Keuls post-hoc analysis was run
when the repeated measure (stranger mouse or novel object) was
significant to determine the group differences. Groom time and
time spent immobile were analyzed using factorial ANOVA and
Newman Keuls post-hoc test. All other experiments were analyzed
using factorial ANOVA, with the main factor being FA dose and
Newman Keuls post-hoc tests. For all experiments, a was set at 0.05.




We analyzed and compared the global gene expression pattern
of the transcripts from the cerebral hemisphere of P1 pups whose
mothers had received FA at two different concentrations
throughout the pregnancy. Comparison of the expression data
revealed that significant numbers of genes were altered in the pups
from whose mothers had received FA at 4 mg/kg. The extent of
extreme gene expression alteration was between 62-fold up-
regulation in females and 18-fold down-regulation in males.
MIAME2compliant data is available in the Gene Expression
Omnibus database of the National Center for Bioinformatics, with
the accession number GSE45607 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE45607).
The results showed that transcripts from 68 genes were down-
regulated (Results Table S2 in File S1) and from 56 genes were up-
regulated by more than two-fold (Results Table S3 in File S1) were
common in both male and female pups from the 4 mg maternal
FA group. Not only were genes altered by the amount of maternal
FA, but there was also an interaction with FA and sexes. In male
pups from the 4 mg maternal FA group, the expression patterns of
over 1000 genes were down-regulated (Results Table S4 in File
S1), and of over 900 genes were up-regulated (Results Table S5 in
File S1) more than two-fold in comparison to the 0.4 mg maternal
FA group. In female pups from the 4 mg maternal FA group, the
expression patterns of over 900 genes were down-regulated
(Results Table S6 in File S1) and of more than 1200 genes were
up-regulated (Results Table S7 in File S1) more than two-fold.
Several transcriptional factors, imprinted genes, and developmen-
tal genes were differentially regulated in the cerebral hemisphere
of both male and female pups as a result of higher FA during
gestational development. Thus, the results of this microarray
analysis indicate that depending on the amount of maternal FA,
the pattern of gene expression varies in the offspring’s cerebral
hemisphere, and higher maternal FA could induce significant
changes.
FA-Mediated Differential Neural Gene Expression Profile
in Newborns’ Cerebral Hemispheres
Because early brain development can influence long-term
susceptibility to neuropsychiatric disorders, we analyzed the
differential expression of neural genes (Tables 1 & 2). We found
that expression of several genes involved in neural function were
altered in the cerebral hemispheres of both male and female
newborn pups born to females in the 4 mg FA group.
Neurotransmitter genes (Chrm4, Htr3a and Htr4), genes related to
glutamatergic synapses (Avp, P2rx7), dopaminergic and serotonin-
ergic pathway genes (Cyp2d22, Nr4a3) and neurogenesis related
genes (S100b, Shh) were down-regulated by more than two-fold in
the cerebral hemispheres of male newborn pups receiving the
4 mg FA dose (Table 1). In female newborn pups from the 4 mg
FA group, genes related to the dopamine-serotonin pathways
(Slc6a4, Slc18a2), synaptic plasticity (Srf), GAP-junctions (Tuba1b),
and the neurotrophin receptor (Nrg4) were down-regulated by
more than two-fold (Table 2). The synaptic motor protein kinesin
17 (Kif17) in male newborn pups and nitric oxide synthase (Nos1)
transcripts in female newborn pups were significantly up-regulated
(Tables 1 & 2). Additionally, 4 mg FA caused a significant up-
regulation of the neurotransmitter Gabra6 in the cerebral
hemispheres of both male and female newborn pups (Tables 1 &
2). These results indicate that the differences in the amount of
maternal FA during gestation can modulate expression of neural
genes in the offsprings’ cerebral hemispheres.
Quantitative RT-PCR Confirmed Alteration of Gene
Expression as a Result of High Maternal FA
To validate the microarray results, qRT-PCR was performed
for nine randomly selected genes (Xist, Nkx6-3, Leprel1, Nfix,
Slc17a7, Cpn2, Htr4, Zfp353, and Vgll2) whose expressions were
altered in male or female newborn pups from 4 mg of maternal
FA. The housekeeping gene Hprt was used as an internal control in
male newborn pups, and Gapdh was used as an internal control in
female newborn pups. Expression of both these genes did not show
differences between the two diet groups. The results of qRT-PCR
(Figures 2A & 2B) showed a similar expression directional pattern
and agreed well with the results of the microarray experiments. In
male newborn pups, the carboxypeptidase N, Cpn2; the zinc finger
Aberrant Gene Expression and Behavior by Folic Acid
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protein, Zfp353; and the serotonin receptor, Htr4; and in female
newborn pups, the vestigial-like 2 gene, Vgll2, were significantly
(P,0.05) down-regulated (Figures 2A & 2B). The imprinted gene,
Xist, and the homeobox gene, Nkx6-3, were up-regulated
significantly (P,0.001), in the cerebral hemispheres of male
newborn pups. Moreover, in female newborn pups from 4 mg
maternal FA supplementation, Leprel1 that encodes an enzyme
critical for collagen chain assembly; Nfix that encode transcrip-
tional factor; and sodium-dependent phosphate transporter,
Slc17a7, were significantly (P,0.05) up-regulated (Figure 2A &
2B). These qRT-PCR results provided further evidence that the
high amounts of maternal FA results in alterations in the gene
expression in newborn’s cerebral hemispheres.
Western Blot Analysis Confirmed High Maternal FA Alters
the Expression of Slc17a7p and Vgll2p in Newborn Pups
Cerebral Hemisphere
In order to confirm that the gene expression changes observed
in microarray analysis and qRT-PCR are translated to protein
functions, we examined whether the alterations in the expression
of Slc17a7 and Vgll2 transcript correlate with the expression of
protein level. Western blot analysis and quantification of the
protein levels using ImageJ software (NIH) revealed a significant
up-regulation in the expression of Slc17a7p (Figures 3A & 3B) and
reduction in the expression of Vgll2p (Figures 3C & 3D) in female
newborn pups whose mothers received high maternal FA. These
results exhibited that the high maternal FA results in alterations in
gene expression in newborns’ cerebral hemispheres. Moreover,
they further confirmed that the differential gene expression
observed in microarray analysis and qRT-PCR as a result of
different amounts of maternal FA are similarly reproduced at the
protein level.
Table 1. Neural genes altered $2 fold in the cerebral hemisphere of male pups from mothers having FA supplementation during
gestation at 4 mg/kg in comparison to mothers at 0.4 mg/kg diet.
Accession Symbol Fold Change Direction of Change Pathway
ref|NM_008313 Htr4 23.70 Q Dopa-Seretonin
ref|NM_013561 Htr3a 23.67 Q Dopa-Seretonin
ref|NM_019823 Cyp2d22 23.04 Q Dopa-Seretonin
ref|NM_015743 Nr4a3 22.60 Q Dopa-Seretonin
ref|NM_001038845 P2rx7 23.96 Q GABA-Glutamate
ref|NM_009732 Avp 23.77 Q GABA-Glutamate
ref|NM_007699 Chrm4 23.12 Q Neuro-transmitter
ref|NM_009170 Shh 23.49 Q Neurogenesis
ref|NM_009115 S100b 22.99 Q Neurogenesis
ref|NM_010291 Gjb5 22.50 Q Gap junctions
ref|NM_008123 Gja8 22.07 Q Gap junctions
ref|NM_019827 Gsk3b 3.27 q Dopa-Seretonin
ref|NM_009414 Tph1 2.48 q Dopa-Seretonin
ref|NM_173391 Tph2 2.14 q Dopa-Seretonin
ref|NM_013761 Srr 2.35 q GABA-Glutamate
ref|NM_182959 Slc17a8 2.30 q GABA-Glutamate
ref|NM_008068 Gabra6 2.15 q GABA-Glutamate
ref|NM_010623 Kif17 2.43 q Synaptic plasticity
ref|NM_008689 Nfkb1 2.25 q Synaptic plasticity
ref|NM_001042528 Cacna1b 2.42 q Neuronal-Ion Channels
ref|NM_145983 Kcna5 2.11 q Neuronal-Ion Channels
ref|NM_008426 Kcnj3 2.09 q Neuronal-Ion Channels
ref|NM_018732 Scn3a 2.07 q Neuronal-Ion Channels
ref|NM_177781 Trpa1 2.00 q Neuronal-Ion Channels
ref|NM_021382 Tacr3 2.20 q Neurotransmitter
ref|NM_009216 Sstr1 2.17 q Neurotransmitter
ref|NM_008312 Htr2c 2.12 q Neurotransmitter
ref|NM_001001496 Gja6 2.07 q Gap Junctions
ref|NM_172989 Lpar1 2.03 q Gap Junctions
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Higher FA Supplementation during Pregnancy and
throughout Life Moderately Modifies Behavior
In order to test whether the dose of maternal FA may lead to
behavior modifications, we first studied the behavior of mice pups
whose mothers were fed FA at 0.4 or 4 mg/kg diets for USVs.
Then pups continued receiving FA diets throughout the lifespan
and were tested for sociability, anxiety, obsessive-compulsiveness,
and learning and memory during adulthood (starting at 8 weeks of
age) in order to assess the behavioral outcome as a result of the
cumulative exposure of gestational and lifelong FA (Results Table
S8 in File S1).
USVs. All of the pups had increases in weight across P2 to P6,
and the males weighed significantly more than the female pups
overall, but sex did not interact with the FA dose or age. The
4 mg/kg pups weighed significantly more than the 0.4 mg/kg
pups overall, which interacted with age. Post-hoc analysis revealed
that the 4 mg/kg pups weighed significantly more on P4 and P6
but not P2 (Figure 4A). The offspring were tested for USVs in
response to maternal separation on P2, P4, and P6. The 4 mg/kg
pups had a longer total duration of calls than the 0.4 mg/kg pups
(Figure 4B). There was no difference between the sexes or age of
the pups. There was an interaction between the dose of FA and the
age of testing as the 0.4 mg/kg pups’ call duration was the longest
at P2 and decreased across age, while the 4 mg/kg pups had their
shortest call duration on P2, and the call duration gradually
increased until P6. This finding was confirmed by post-hoc analysis
of the interaction between age and FA dose, which revealed a
difference between the FA groups on P2, where the 4 mg/kg pups
made longer calls than the 0.4 mg/kg pups, but not on P4 and P6.
The mice exposed to FA at 4 mg/kg diet in utero and throughout
the experiment emitted more USVs than did the 0.4 mg/kg group
(Figure 4C). This finding did not differ by the sex or the age of the
pups. There were no interactions of FA dose, age of testing, or sex.
Trace Fear Conditioning. Figure 4D shows the percent
freezing data from the trace fear conditioning test. FA dose did not
affect freezing behavior during training or contextual fear
conditioning, but there was an increase in freezing after the cue
was presented in the 0.4 mg/kg mice. All of the mice froze
significantly more following training than during baseline. There
were no differences in freezing on the training day between the 0.4
and 4 mg/kg FA groups. On the next day when the animals were
placed in the same context without the tone or shock, both FA
groups froze to a similar extent. On day 3, the mice were placed
into a novel context and exposed to the tone. All of the mice froze
more when the tone was on than during the pre-tone or post-tone
time periods. FA dose did affect freezing levels overall. There were
no differences between the FA groups during the baseline or when
the tone was on. However, the 4 mg/kg FA mice froze
significantly less in the post-tone period than did the 0.4 mg/kg
mice. There was no effect of sex in any of the measures (details in
Results S1 in File S1).
Open Field. Figure 4, panels’ E-H illustrate the data from the
open field exploration test. Mice were placed into the open field,
Table 2. Neural genes altered $2 fold in the cerebral hemisphere of female pups from mothers having FA supplementation
during gestation at 4 mg/kg in comparison to mothers at 0.4 mg/kg diet.
Accession Symbol Fold Change Direction of Change Pathway
ref|NM_172523 Slc18a2 23.14 Q Dopa-Seretonin
ref|NM_010484 Slc6a4 22.84 Q Dopa-Seretonin
ref|NM_198190 Ntf5 23.30 Q Neurotrophin receptor
ref|NM_032002 Nrg4 22.28 Q Neruotrophin receptor
ref|NM_145129 Chrna3 22.13 Q Neurotransmitter
ref|NM_001037712 Kcnh6 22.09 Q Neuronal-Ion Channels
ref|NM_020493 Srf 22.98 Q Synaptic plasticity
ref|NM_011654 Tuba1b 23.32 Q Gap junctions
ref|NM_011198 Ptgs2 3.83 q Dopa-Seretonin
ref|NM_138942 Dbh 2.40 q Dopa-Seretonin
ref|NM_019911 Tdo2 2.12 q Dopa-Seretonin
ref|NM_008068 Gabra6 12.82 q GABA-Glutamate
ref|NM_182993 Slc17a7 4.81 q GABA-Glutamate
ref|NM_008066 Gabra2 4.02 q GABA-Glutamate
ref|NM_205783 Chrm5 4.29 q Neuro-transmitter
ref|NM_007726 Cnr1 3.30 q Neuro-transmitter
ref|NM_009217 Sstr2 2.39 q Neuro-transmitter
ref|NM_007578 Cacna1a 2.34 q Neuronal-Ion Channels
ref|NM_008427 Kcnj4 2.20 q Neuronal-Ion Channels
ref|NM_013627 Pax6 2.25 q Neurogenesis
ref|NM_144939 Frs3 2.60 q Neruotrophin receptor
ref|NM_008712 Nos1 2.17 q Synaptic plasticity
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and time immobile, distance travelled, speed and center time were
recorded across 15 min. Male mice from the dams fed the 4 mg/
kg diet showed increased hyperactivity at the beginning of the test.
The distance traveled was highest at the beginning of the test and
dropped as shown by a significant effect of time bin (Figure 4E).
Post-hoc analysis revealed that the 4 mg/kg males travelled a
significantly greater distance than the 0.4 mg/kg males during the
first three time bins. There were no differences between the female
mice on distance traveled. The data for the speed of the mice were
very similar, as the mice travelled at a greater speed at the
beginning of the test (Figure 4F). This was shown by an effect of
time bin. Post-hoc analysis revealed that the 4 mg/kg males moved
at a greater speed than the 0.4 mg/kg males during the first three
time bins. There was no difference between the females in the
speed measure. Overall time immobile differed across the
experiment (Figure 4G). Post-hoc analysis of the treatment groups
by sex showed that the 4 mg/kg males spent significantly less time
immobile during the first two time bins compared to the 0.4 mg/
kg males. There were no differences between the female FA
groups, nor there were any effects of FA or time bin on percent
center time (Figure 4H). This was shown by lack of a significant
effect of time bin. Post-hoc analysis revealed that the 0.4 mg/kg
females spent a significantly greater percentage of time in the
center compared to the 0.4 mg/kg males in the second and third
time bins. There were no differences within the females or males
due to FA dose.
Social Approach, Elevated Plus Maze, Spontaneous
Grooming, Marble Burying and Buried Food. In the social
approach test, offspring from both doses of FA demonstrated social
behavior with a significant preference for the chamber with the
stranger mouse and time spent sniffing the stranger mouse (File
S1). Neither treatment elicited greater levels of anxiety-like
behavior, as shown by no difference in percent open arm time
or percent open arm entries. There was no difference in repetitive
grooming between the 0.4 mg/kg and 4 mg/kg groups, or
between the sexes, or interaction between treatment and sex.
There was no difference between the FA groups on obsessive-
compulsive like behavior, as shown by the number of marbles
buried (File S1, Table S8), which was not affected by sex and FA.
Neither group showed an olfactory deficit in finding the buried
food (File S1, Table S8). There was no difference between the
sexes and sex did not interact with the FA dose.
Discussion
Fetal gestational development is controlled by precise regulation
of gene expression, and epigenetics plays a crucial role in
regulating gene expression during development. Recently we
reported that maternal FA during gestation induces a substantial
alteration in methylation patterns (both hypo- and hyper-) in a site-
specific manner both in CpG and non-CpG contexts throughout
the genome of offspring cerebral hemispheres [15]. In the current
study, we have found that changes in the amount of FA in the
maternal diet during gestation dysregulates gene expression in the
newborns’ cerebral hemispheres, and gestational and lifelong
exposure to higher levels of FA moderately modified the pups’
behavior. Key developmental genes including those involved in
neural pathways, neurotransmitters, neuronal-ion channels,
GABA and glutamatergic-synapse, dopamine-serotonin and syn-
aptic plasticity which may modulate the behavior of offspring,
exhibited alterations in expression due to the higher level of FA
supplementation. For example, Kif17, which plays an important
Figure 2. A: Quantitative RT-PCR confirmation of microarray data. Relative expression of the Cpn2, Zfp353, Htr4, Nkx6-3 and Xist transcripts in
the cerebral hemispheres of male newborn pups, from mothers supplemented with FA at 4 mg/kg of diet. The results were normalized to Hprt
transcript expression, and expressed as relative values in comparison to corresponding transcripts from newborn pups with FA at 0.4 mg/kg diet.
Results represent means 6 S.D; asterisks denote statistically significant change (***P,0.001, **P,0.01 and *P,0.05). B): Quantitative RT PCR
confirmation of microarray data. Relative expression of the Vgll2, Leprel1, Nfix and Slc17a7 transcripts from the cerebral hemispheres of female
newborn pups, from mothers supplemented with FA at 4 mg/kg of diet. The results were normalized to Gapdh transcript expression, and were
expressed as relative values in comparison to corresponding transcripts from newborn pups with FA at 0.4 mg/kg diet. Results represent means 6
S.D; asterisks denote statistically significant change (***P,0.001, **P,0.01 and *P,0.05).
doi:10.1371/journal.pone.0101674.g002
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role in the transport of vesicles containing the N-methyl-D-
aspartate receptor and the K+ channel subunit Kv4.2 to dendrites
in mammals [30,31], was up-regulated by more than two-fold in
the cerebral hemispheres of male newborn pups from mothers that
received higher FA diets. Because the kinesin superfamily of
proteins play important roles in receptor transportation, and Kif17
contributes to neuronal development, such alteration of Kif17
expression may modulate synaptic plasticity in the offspring brain.
Likewise, female newborn pups from higher maternal FA
supplementation exhibited an up-regulation of the Nos1. In this
regard, a recent study has shown that schizophrenic patients show
significant up-regulation of Nos1 in their dorsolateral-precerebral
cortices [32]. Consequent to changes in gene expression, we found
a moderate alteration in behavioral outcome when offspring were
assessed behaviorally. Pups from dams exposed to a higher dose of
FA during gestation and lactation made increased USVs as
neonates; these behaviors may have originated from FA induced
alteration of gene expression during the gestational period.
Increased USVs have been found in mouse models for autism
[33,34]. Anxiety symptoms are highly prevalent in children with
developmental disorders, including autism [35]. Of note, our result
of microarray and qRT-PCR shows significant down-regulation in
the expression of Htr4 in the cerebral hemispheres of male
newborn pups of higher maternal FA. Htr4 is considered as a
putative candidate gene for autism and was found to be
differentially expressed in lymphoblastoid cell lines from individ-
uals with autism spectrum disorders [36,37]. Htr4 is known to
modulate the release of neurotransmitters, and irregularities in
serotonergic neurotransmission have been linked to a variety of
neuropsychiatric diseases [38]. Alterations in Htr4 expression as a
result of higher FA during gestational development may play a role
in the genetic predisposition to psychiatric diseases. Similarly, the
expression of Slc17a7 was up-regulated significantly both at the
mRNA and the protein levels in female newborn pups born to
mothers that received a high FA diet. Slc17a7 is known to be
expressed mainly in the axon terminals of neocortical neurons, and
to critically modulate the efficacy of glutamatergic synaptic
transmission [39–43]. Several studies have shown that alterations
in expression of vesicular glutamate transporters impact various
brain disorders including schizophrenia, Parkinson’s disease and
Alzheimer’s disease; moreover, a recent study has shown increased
expression of Slc17a7 in the white matter of schizophrenic patients
[44,45]. Considering the functional role of Slc17a7 in synaptic
plasticity, the up-regulation in the expression of Slc17a7 in cerebral
hemispheres of female newborn pups as a result of high maternal
FA may cause consequent changes in behavior as observed in this
study. However, behavior modification may result from a
cumulative effect of high FA during gestational development as
well as post-weaning period.
Furthermore, the qRT-PCR data also showed alterations in the
expression of Nfix and Vgll2 in female newborn pups and Nkx6–3 in
male newborn pups from high maternal FA. The expression of
Nfix that was shown to play a central role in hippocampal
morphogenesis [46], was significantly up-regulated, and the
expression of Vgll2 was down-regulated in female newborn pups
from mothers fed higher FA diets. The biological consequences of
such down-regulation in the expression of Vgll2 may have far-
reaching implications, as vestigial-like genes are reported to
Figure 3. High maternal FA alters the expression of Slc17a7p and Vgll2p in the cerebral hemispheres of female newborn pups. Total
cell lysates from the cerebral hemispheres of female (F) newborn pups were prepared from both 0.4 mg/kg and 4 mg/kg FA diet groups and proteins
were resolved on 10% Tris/HEPES/SDS-polyacrylamide gels. The blot was probed with Slc17a7p antibody (A, B) or with Vgll2p antibody (C, D). To
confirm equal protein loading, the membranes were re-probed with GAPDH/b-tubulin antibodies. The left panel represents one representative blot
and the right panel shows densitometric evaluation of two independent experiments. Densitometric evaluation of the bands were calculated by
using the Image J software and normalized to the densities of GAPDH//b-tubulin. The values corresponding to 0.4 mg/kg FA diet were arbitrarily set
to 100%, and the 4 mg/kg values are presented relative to this. The densitometric values represent the mean, and the error bar represents the inter-
variability among independent experiments.
doi:10.1371/journal.pone.0101674.g003
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modulate cell fate and embryonic patterning [47]. Nkx6-3, which
controls numerous developmental processes including the central
nervous system, was also up-regulated in male newborn pups from
mothers fed higher FA diets. We speculate that mechanistically
such changes in gene expression may be modulated more in a site-
and gene-specific manner with the methylation of individual CpGs
due to high maternal FA. These gene expression changes could be
the direct result of methylation of specific cytosine residues, both in
CpG and other contexts, as we have recently reported [15].
Methylation data is available in the NCBI SRA with accession
number SRX482108. Cytosine methylation may affect the gene
expression either in cis-configuration affecting expression of the
Figure 4. FA supplementation during gestational development and post-weaning period modifies behavior. Ultrasonic vocalizations
(panels A–C). Juvenile mice were recorded for 5 min upon separation from their dams. There were no differences between the sexes in any of these
measures. A) The mice exposed to FA at 4 mg/kg weighed more on P4 and P6 than the 0.4 mg/kg-exposed mice. B) The mice exposed to FA at
4 mg/kg made longer calls on P2, but not on P4 and P6. C) The mice exposed to FA at 4 mg/kg made significantly more calls than the 0.4 mg/kg
group. D) Trace fear conditioning. FA did not affect learning and memory in mice. The graph presents the group averages for the percentage of time
spent freezing from the different stages of the experiment. The 4 mg/kg group froze less after the tone ended during the cued fear conditioning
(0.4 mg/kg n= 16; 4 mg/kg n=16). Open field. E) The 4 mg/kg males travelled the longest distance in each 3 min bin across the 15 min compared to
the other sexes and treatment groups. The 0.4 mg/kg males travelled the least distance at the beginning of the test and became less mobile as the
test progressed. Both the 0.4 and 4 mg/kg females were more active at the beginning and spent more time immobile later in the test period. a:
significantly (P,0.05) different than the 0.4 mg/kg males; b: significantly different (P,0.05) than the 4 mg/kg males. F) The total distance travelled by
the 4 mg/kg males over the entire 15 min was significantly greater than the 0.4 and 4 mg/kg females, but not the 0.4 mg/kg males (0.4 mg/kg, males
n = 6; females n = 9; 4 mg/kg, males n = 11, females n= 9). G) Overall time immobile differed across the experiment. The 4 mg/kg males spent
significantly less time immobile during the first two time bins compared to the 0.4 mg/kg males. There were no differences between the female FA
groups. H) There were no effects of FA or time bin on percent center time; however, the 0.4 mg/kg females spent a significantly greater percentage
of time in the center compared to the 0.4 mg/kg males in the second and third time bins. Open field asterisks denote significant differences from the
alow versus high FA groups, and between bmales versus females. For all graphs: *P,0.05; **P,0.01; ***P,0.001 was used.
doi:10.1371/journal.pone.0101674.g004
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same gene and/or reading frame, or methylation of one gene may
modulate expression of another gene elsewhere in the genome in a
trans-configuration. While it is a logical conclusion that gene
expression changes during gestational development may have
contributed to the changes in behaviors, more direct evidence is
necessary. These conclusions, however, will have to be confirmed
by direct sequencing methods. We also cannot exclude alternative
mechanisms, as DNA methylation is also modulated by other
factors such as methylenetetrahydrofolate reductase (MTHFR)
activity, and is not restricted on folate status alone [48,49].
Next, we analyzed whether the amount of FA received during
gestation and throughout the lifespan impacts the behavior of
offspring. The results of our behavioral studies have shown that
higher FA exposure resulted in males being more active in the
open field during adulthood. This finding is reflected in the open
field test, which measures the general exploratory behavior of mice
in a novel environment in which the males in the higher FA group
travelled a greater distance. In this context, we found that in male
newborn pups, the expression of the imprinted gene Xist was up-
regulated by 90 fold. Xist is well known for its actions in
transcriptional silencing and plays an important role in develop-
mental components by modulating dosage compensation [50,51].
Moreover, previous studies have shown that XIST is over-
expressed in males diagnosed with Klinefelter syndrome compared
to XY controls, suggesting a silencing of many genes on the X
chromosome, resulting in dysregulation of X-linked gene expres-
sion [52]. Gender differences observed in gene expression
alteration could be the result of genomic imprinting and X-
inactivation. Some of the gender-related differences in gene
alteration may explain the differences in behaviors between the
males from the higher-dose group being more active than females.
Of note, some of the behavior resulting from higher FA that we
found in this study may have been caused by alterations in
methylation levels, as aberrant DNA methylation is associated with
reduced neurogenesis and increased genomic instability, and has
been linked to cognitive impairments, including fragile X and Rett
syndromes [53–55]. However, this study found no differences in
social behavior or learning and memory between the two groups.
Thus, the result of the behavioral study indicates that gestational
and lifelong exposure to higher levels of FA may impact some
behavioral changes, if not drastic alterations. One caveat of our
experimental design is that it continued a FA-rich diet during the
post-weaning period. Therefore, it cannot be determined whether
the changes in behavior observed in this study are due to excess
FA during gestational/lactational development or to continued
postnatal supplementation. In the future, studies of FA-rich diets
restricted to during gestational development or stopped upon
closure of the neural tube should clarify this aspect, as well as
ascertain whether excess FA-induced unintended changes can be
minimized or eliminated.
Conclusions
In view of a recent report that FA consumed by pregnant
women four weeks prior to and 8 weeks after conception in
Norway contributes to a lower risk of autism [56], it is clear that
the timing of FA supplementation is critical. There is also the
possibility of genetic predisposition that would make certain at-risk
populations more susceptible to changes in dietary epigenetic
factors. Thus, autism may have genetic predisposition, which is
exacerbated with environmental contributors such as epigenetic
factors. Additionally, a recent study in rodents has shown that FA
may be useful in clinical interventions to promote brain and spinal
cord healing; however higher dose-induced decreased axonal
regeneration, which may be associated with reduced de novo
methyltransferase levels, indicates a ceiling on the regenerative
potential provided by FA supplementation [57]. We suggest that
moderation of FA supplementation be exercised during gestation
and during the life span, as alterations of nutrient intake may
modulate susceptibility to various diseases. Our findings demon-
strate both that FA is an important contributing factor that can A)
alter global gene expression, B) epigenetically reprogram brain
structure, and C) affect its function, and that there may be a loss of
benefit from higher amounts of FA. Even though numerous genes
were identified as being altered in our study, it is unlikely that all
these genes will have adverse consequences as shown by the
behavior analysis of our data (no differences in social behavior or
learning and memory). In the future, it will be of interest to
determine whether the alteration of gene expression has a
combined, cumulative influence in reprogramming of the normal
development of the brain.
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